Various cell membrane abnormalities affecting different cell populations, such as muscle cells, erythrocytes, T lymphocytes, and B lymphocytes, have been described in DMD by several ininvestigators. '-3 In spite of the fact that the basic defect is still unknown, a large number of studies have been performed to establish the usefulness of these membrane phenomena as a diagnostic test in antenatal diagnosis and carrier detection.'-10 One of the main functional defects in DMD cell membranes has been shown to be B lymphocyte Ig capping capacity.'2 [4] [5] [6] [7] [8] [9] [10] According to the 'fluid mosaic theory' of cell membrane organisation proposed by Singer and Statistical evaluation of the capping percentage differences observed in healthy subjects and DMD patients, performed by the Mann-Whitney U test, showed p<0 00003. The distribution of the capping capacities, detected by anti-HLA serum on the whole peripheral lymphocyte population in healthy subjects and DMD patients, is shown in the figure. In DMD patients cap capacities showed a negative correlation with CK levels ('r = -0 507, p = 0 038) and a positive correlation with age (T = + 0 657, p = 0-012). Analysis of the data, performed by the Kendall partial rank correlation coefficient, confirmed the significant correlation between cap and age when CK was partialled out (T = + 0 604), while the correlation between cap and CK when age was held constant showed a reduction to = +0-126. In conclusion, HLA capping performed on the whole lymphocyte population of peripheral blood seems to overcome some difficulties of Ig capping evaluation. Moreover, HLA capping shows no overlap between the ranges obtained in DMD patients and healthy controls, suggesting good results in the detection of the cellular impairment in DMD.
The normal range of the HLA capping capacities evaluated in the healthy newborn controls and the small amount of peripheral blood required could recommend our method as a diagnostic aid in the antenatal detection of hemizygous DMD males, unless the low disease activity in the fetus interferes with the detection of the systemic cellular impairment, because of the hypothesised relation with the cap capacity.
Furthermore, the results suggest that HiLA investigation of DMD heterozygous females might be a method of carrier detection not related to CK serum levels.
